Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2009Hereditary Cancer in Clinical PracticeOpen Access

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDewkoemar RamsoekhAmsterdam University Medical CentersAWAnja WagnerErasmus MCMLMonique E. van LeerdamLeiden University Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ramsoekh et al. (2009) studied this question.

synapsesocial.com/papers/6a7577de01b447f0dadc27dbhttps://doi.org/10.1186/1897-4287-7-17
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations2008 · 102 citations
  2. 2Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree2001 · 167 citations
  3. 3The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome2008 · 598 citations
  4. 4The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma2002 · 229 citations